Triangle Securities Wealth Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$555K Sell
2,617
-30
-1% -$5.89K 0.11% 157
2026
Q1
$519K Sell
2,647
-37
-1% -$7.19K 0.12% 156
2025
Q4
$466K Hold
2,684
0.1% 165
2025
Q3
$512K Sell
2,684
-25
-0.9% -$4.44K 0.12% 155
2025
Q2
$487K Sell
2,709
-45
-2% -$7.82K 0.12% 151
2025
Q1
$466K Sell
2,754
-45
-2% -$7.39K 0.12% 155
2024
Q4
$422K Sell
2,799
-200
-7% -$31.1K 0.11% 157
2024
Q3
$466K Sell
2,999
-30
-1% -$4.48K 0.12% 156
2024
Q2
$415K Sell
3,029
-225
-7% -$30.8K 0.12% 159
2024
Q1
$433K Sell
3,254
-199
-6% -$25.8K 0.12% 154
2023
Q4
$476K Buy
3,453
+563
+19% +$74K 0.15% 144
2023
Q3
$352K Sell
2,890
-300
-9% -$40K 0.13% 154
2023
Q2
$448K Hold
3,190
0.15% 142
2023
Q1
$451K Hold
3,190
0.16% 142
2022
Q4
$499K Sell
3,190
-155
-5% -$22.3K 0.18% 131
2022
Q3
$410K Sell
3,345
-40
-1% -$5.27K 0.17% 135
2022
Q2
$450K Sell
3,385
-65
-2% -$8.86K 0.18% 135
2022
Q1
$472K Sell
3,450
-195
-5% -$27.2K 0.16% 137
2021
Q4
$631K Sell
3,645
-50
-1% -$7.61K 0.2% 127
2021
Q3
$537K Sell
3,695
-20
-0.5% -$2.93K 0.18% 128
2021
Q2
$490K Sell
3,715
-195
-5% -$25.5K 0.17% 132
2021
Q1
$502K Buy
3,910
+35
+0.9% +$4.31K 0.18% 127
2020
Q4
$462K Sell
3,875
-120
-3% -$14.6K 0.18% 128
2020
Q3
$457K Sell
3,995
-15
-0.4% -$1.77K 0.21% 118
2020
Q2
$457K Sell
4,010
-325
-7% -$34.5K 0.22% 115
2020
Q1
$348K Sell
4,335
-25
-0.6% -$2.59K 0.2% 115
2019
Q4
$466K Sell
4,360
-164
-4% -$17.1K 0.2% 115
2019
Q3
$484K Sell
4,524
-20
-0.4% -$2.05K 0.24% 111
2019
Q2
$466K Buy
4,544
+76
+2% +$7.3K 0.24% 105
2019
Q1
$402K Sell
4,468
-100
-2% -$8.66K 0.21% 110
2018
Q4
$380K Sell
4,568
-450
-9% -$42.2K 0.22% 104
2018
Q3
$541K Sell
5,018
-70
-1% -$7.68K 0.29% 94
2018
Q2
$559K Sell
5,088
-30
-0.6% -$3.13K 0.31% 90
2018
Q1
$513K Sell
5,118
-30
-0.6% -$3.07K 0.29% 98
2017
Q4
$507K Hold
5,148
0.29% 94
2017
Q3
$482K Hold
5,148
0.29% 91
2017
Q2
$572K Sell
5,148
-100
-2% -$10.6K 0.38% 75
2017
Q1
$515K Buy
5,248
+310
+6% +$29.6K 0.33% 83
2016
Q4
$454K Sell
4,938
-500
-9% -$43.1K 0.3% 85
2016
Q3
$460K Sell
5,438
-1,295
-19% -$109K 0.32% 84
2016
Q2
$548K Sell
6,733
-5,397
-44% -$411K 0.41% 73
2016
Q1
$867K Sell
12,130
-475
-4% -$31.9K 0.57% 56
2015
Q4
$897K Sell
12,605
-50
-0.4% -$3.36K 0.6% 55
2015
Q3
$778K Sell
12,655
-575
-4% -$40.2K 0.59% 55
2015
Q2
$959K Sell
13,230
-370
-3% -$27.3K 0.68% 51
2015
Q1
$1.04M Sell
13,600
-140
-1% -$10K 0.72% 48
2014
Q4
$921K Buy
13,740
+1,325
+11% +$83.6K 0.66% 52
2014
Q3
$753K Sell
12,415
-40
-0.3% -$2.46K 0.58% 65
2014
Q2
$731K Sell
12,455
-1,186
-9% -$69.5K 0.56% 65
2014
Q1
$770K Buy
13,641
+1,836
+16% +$98.4K 0.69% 51
2013
Q4
$632K Sell
11,805
-285
-2% -$16.9K 0.51% 67
2013
Q3
$747K Sell
12,090
-758
-6% -$45.4K 0.65% 55
2013
Q2
$779K Buy
+12,848
New +$765K 0.58% 53

Other funds holding DGX

Triangle Securities Wealth Management's DGX Position: Q2 2026 in Review

Triangle Securities Wealth Management reduced its Quest Diagnostics (DGX) stake by 1.1% in Q2 2026, selling an estimated $5.89K and leaving 2,617 shares worth $555K. The position accounts for 0.11% of the portfolio, ranked #157.

Triangle Securities Wealth Management first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.04M in Q1 2015. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Triangle Securities Wealth Management held 2,617 shares of Quest Diagnostics worth $555K as of Q2 2026.
  • Triangle Securities Wealth Management sold 30 Quest Diagnostics shares in Q2 2026, an estimated $5.89K.
  • Quest Diagnostics made up 0.11% of Triangle Securities Wealth Management's portfolio in Q2 2026, its #157 holding.
  • Triangle Securities Wealth Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
  • Triangle Securities Wealth Management's Quest Diagnostics position peaked at $1.04M in Q1 2015.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Triangle Securities Wealth Management's 13F filing for Q2 2026, filed 14 Jul 2026.